ForecastRFI
AJ13--Pharmarcokinetics for Experimental Rheumatoid Arthritis treatment
VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.245-NETWORK CONTRACT OFFICE 5 (36C245)
AI Overview
GLP-compliant preclinical toxicology and pharmacokinetic studies for peptide-displaying liposomal dexamethasone delivery system targeting rheumatoid arthritis, supporting FDA Pre-IND advancement.
This summary is AI-generated from the official solicitation.
Key Details
Agency
VETERANS AFFAIRS, DEPARTMENT OF
Funding Amount
—
Release Date
July 16, 2026
Due Date
July 31, 2026
Official Description
SOURCES SOUGHT NOTICE Department of Veterans Affairs Network Contracting Office (NCO) 05 Title: A Joint Targeted Drug Delivery Approach for Arthritis Therapy Toxicity and Pharmacokinetics
- Purpose This Sources Sought Notice is issued solely for market research in accordance with FAR Part 10. This is not a solicitation, and it does not commit the Government to issue a solicitation or make an award. The Department of Veterans Affairs (VA) seeks to identify qualified vendors capable of performi...
Change History
Opportunity AddedJul 16, 2026 at 1:03 PM
AJ13--Pharmarcokinetics for Experimental Rheumatoid Arthritis treatment
New SAM.gov opportunity: AJ13--Pharmarcokinetics for Experimental Rheumatoid Arthritis treatment
Similar Opportunities
Forecast
AJ13--Liposome Preparation for Experimental Rheumatoid Arthritis treatment
Due July 31, 2026
ForecastR408--Request For Information Health Architecture Services and Standardization (HASS)
Due July 23, 2026
ForecastR499--Insurance Entry and Verification Buffer Support Services - CPAC [VA-26-00073096]
Due July 20, 2026
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial